NET Pancreas – V9: 2024+
Primary Site | Histology | Year of Diagnosis |
---|---|---|
C250-C254, C257-C259 | 8150-8153, 8155-8156, 8158, 8240-8242, 8249, 8272, 8683 | 2024-9998, 9999, <BLANK> |
Notes
8150-8153, 8155-8156, 8158, 8240-8242, 8249, 8683 C250 Head of pancreas C251 Body of pancreas C252 Tail of pancreas C253 Pancreatic duct C254 Islets of Langerhans C257 Other specified parts of pancreas C258 Overlapping lesion of pancreas C259 Pancreas, NOS **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 34 *Neuroendocrine Tumors of the Pancreas*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. * *Neuroendocrine Tumors of the Pancreas*, from the AJCC Cancer Staging System Version 9 (2023). Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** For tumors of the islet cells, determine which subsite of the pancreas is involved and use that primary site code. If the subsite cannot be determined, use the general code for Islets of Langerhans, C254.Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | Yes |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
Tumor Size Summary | 999 | Yes |
NAACCR #756
tumorSizeSummary |
None | |
Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
Ki-67 (MIB-1) | XXX.8 | No |
NAACCR #3863
ki67 |
SEER 2021– | SSDI 2021– |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Schema ID | 09340 |
NAACCR #3800
schemaId |
None | |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |